Contact Us

TOURISM NEWS

Kemi Badenoch slates Foreign Secretary David Lammy as 'not serious' mocking him for BBC Mastermind appearance saying Henry VII succeeded Henry VIII

Sep 18, 2024

Kemi Badenoch ramped up tensions with David Lammy after he suggested climate change was a bigger threat than Vladimir Putin.

Unveil the Magic of Fall with Suika Game's '[Autumn Version] Special Skin Pack'

Sep 18, 2024

TOKYO,Sept. 17,2024-- Aladdin X Inc.,a subsidiary of the award-winning projector and laser projector brand XGIMI,iscelebrating the autumn with the global launch of the \'[Autumn Version] Special Skin

Tineco Expands PURE ONE Portfolio with Two New Cutting-Edge Cordless Smart Vacuums

Sep 18, 2024

Revolutionizing Clean with Advanced Capabilities and Superior Performance SEATTLE,Sept. 17,2024-- Tineco,a global leader in intelligent home appliances with an emphasis on innovative floor care items,

Zoetis to Introduce First Cartridge-Based AI-Powered Haematology Analyser

Sep 18, 2024

Zoetis is introducing Vetscan® OptiCellâ„¢ to Australia as it continues to transform diagnostics with its suite of integrated products and services

Metabolon Expands Integrated Bioinformatics Platform to Include Advanced Statistical Analysis Tool

Sep 18, 2024

New tool plays a critical role in supporting complex multiomic research initiatives by helping scientists design and execute customized statistical analyses

Ascletis Enters the Obesity Drug Space with Announcement of Two Ongoing U.S. Phase I Clinical Trials Utilizing Its Small Molecule GLP-1R Agonist ASC30 for Both Once-Monthly Subcutaneous Injection and Once-Daily Oral Tablet for the Treatment of Obesity

Sep 18, 2024

- ASC30 is the first and only small molecule GLP-1 receptor (GLP-1R)agonist that can be dosed once-monthly subcutaneously and once-daily orally to treat obesity

1 ... 274 275 276 277 278 279 280 ... 354